intloko_bn_img

I-COVID-19 NAb(FIA)

I-COVID-19 ye-antibody engathathi hlangothi

  • Ukumiselwa kobungakanani be-S-RBD ye-Neutralization Antibody
  • (Fluorescence Immunochromatographic Assay)

Iinkcukacha zeMveliso

Iithegi zeMveliso

Ngaba isitofu sakho sokugonya siyasebenza ?

I-SARS-CoV-2 (COVID19) iyagquba kwihlabathi jikelele, kwaye ugonyo luvunywa njengeyona ndlela inoqoqosho nesebenzayo yokulawula ubhubhane wentsholongwane.Uvandlakanyo lwesitofu sogonyo lwesintu ikakhulu lusebenzisa iindlela zokubhaqa ii-antibody ukuze zivavanye ukusebenza kogonyo ngokusebenzisa imifuniselo yokungathathi hlangothi;

Iindlela zesiNtu zidla ixesha kwaye zisebenza kancinci, zihlala zithatha iintsuku ezi-2 ukuya kwezi-4 ukugqiba uphononongo, kwaye ngenxa yokuba uninzi lwazo zisebenzisa iintsholongwane eziphilayo, Kufuneka kuqhutywe kwinqanaba le-biosafety 3 okanye ngaphezulu kwilabhoratri, elixesha- idla kwaye ibulaleka, kwaye izisa inkxamleko enkulu kuvavanyo lokwandiswa nokuhlanganiswa.Ke ngoko, kukho imfuno engxamisekileyo yendlela elula nekhawulezayo eyenye ekulungeleyo ukuphononongwa kwezilwa-buhlungu ezikhuselayo kuluntu olukhulu.

I-Aehealth COVID19 I-Neutralization Antibody Quantitative Test Kit isetyenziselwa ukufunyaniswa ngokobungakanani be-COVID19 antibodies kwiserum yomntu, iplasma okanye igazi elipheleleyo.Ingasetyenziselwa ukufunyanwa ngokukhawuleza, ubuninzi kunye nobuthathaka kakhulu kwi-vitro.isetyenziswe eklinikhi kuvavanyo oluncedisayo lwesiphumo sesitofu esitsha se-coronavirus kunye novavanyo lwe-anti-anti-anti-anti-un-uncleing kwizigulana ezibuyiselweyo emva kosulelo.

I-COVID19 Neutralization Antibodies (nAbs)

Ii-antibodies ezingathathi hlangothi kulumisa ngokufanelekileyo usulelo ngokuthintela unxibelelwano phakathi kwentsholongwane ye-COVID19 kunye neeseli ezibambayo.Uninzi lwe-antibodies engathathi hlangothi luphendula kwi-domain binding domain (RBD) yeprotein ye-spike, ebophelela ngokuthe ngqo kwi-cell surface receptor ACE2.Amajoni omzimba-kwi-intanethi okwangoku abonelela ngezilwa-buhlungu ezibini zokungathathi hlangothi ezisekwe kwi-Clone CR3022.Ngelixa uninzi lwe-S-protein ye-RBD ebopha izilwa-buhlungu zikhuphisana ngokubophelela i-antigen nge-ACE2, i-CR3022 epitope ayidibani nesiza sokubopha i-ACE2.

Ngoko ke ayikuthinteli ukubophelela kwezilwa-buhlungu ezingathathi hlangothi.Ngelixa i-CR3022 ngokwayo ibonakalisa kuphela isiphumo esibuthathaka sokungathathi hlangothi, ibonakalisiwe isebenzisana nezinye ii-S-protein RBD ezibophelela izilwa-buhlungu zokulwa i-COVID19.

I-COVID19 Neutralization Antibodies (nAbs)

Balaselisa iimpawu

Ukusebenza lula

  • Akukho mfuneko yokuba iingcali ziqeqeshwe;
  • Imfuno yesampula ephantsi, ifuna kuphela i-50 μL;
  • Iyahambelana nohlobo oluninzi lwesampulu: iSerum/Plasma/Igazi elipheleleyo.

Uvakalelo oluphezulu

  • Uvakalelo: 98.95%;
  • Ukuchaneka: 100%.

Isebenza kakuhle

  • Ixesha lokuphendula: Imizuzu eyi-15, Ixesha lovavanyo: 10s;
  • Iprotable, Usetyenziso olubanzi lweemeko;
  • Ibhetri eyakhelwe-ngaphakathi, ngaphezu kweemvavanyo ezingama-200 ngaphandle kokufakwa kwamandla.

Uthembekile

  • Ingqinwe ngovavanyo lwezonyango ezingama-3600, iimvavanyo ezili-1500 ngomzekelo womntu owosulelekileyo, iimvavanyo ezingama-900 kwizitofu, iimvavanyo ezili-1200 ngabantu abaqhelekileyo.;
  • Idatha yezonyango ifunyenwe kubagonyeli ngesitofu esingasebenziyo, isitofu sokugonya se-nucleic acid, isitofu sokugonya seprotheyini, kunye nabantu abosulelwe yintsholongwane, abantu abaqhelekileyo.
  • Ukunciphisa ixabiso lokunqanda izinga le-30%.
Balaselisa iimpawu

Fluorescence Immunochromatographic Assay Principle

Fluorescence Immunochromatographic Assay Principle

Umgaqo osisiseko osetyenziswa kule kit ukhuphiswano lwe-immunochromatographic.Umgca wokufumanisa (T-line) kumgca wokuvavanya ufakwe kwi-angiotensin yokuguqula i-enzyme 2 kunye nomgca wokulawula (i-C-line) ifakwe kwi-anti-rabbit ye-IgG yebhokhwe. I-conjugate pad igqunywe nge-fluorescently ebhalwe iprotein ye-COVID19 RBD kunye ne-fluorescent ebhalwe ngomvundla we-IgG antibody.Ngexesha lokufunyanwa, xa isampuli iqulethe i-antibody eza kuvavanywa, i-conjugate yento yovavanyo kwisampulu kunye ne-fluorescent antigen yenza i-immune complex kwaye i-immune complex ayinakuphinda ibophe kwi-angiotensin-converting enzyme 2 immobilized kwi-nitrocellulose membrane. .I-fluorescent antigen conjugate engabotshwanga kwi-antibody ukuba ivavanywe iya kubophelela kwi-angiotensin converting enzyme 2 immobilized kwi-nitrocellulose membrane ukwenza umgca wokufumanisa (T).

Ukusetyenziswa kwe-Neutralizing Antibodies kwi-COVID19

  • Uvavanyo lokuhlola phambi kokugonywa;
  • Ukubeka iliso kwiziphumo emva kokugonywa;
  • Uvavanyo lomngcipheko wosulelo lwesibini lwabantu abosulelekileyo;
  • Ukuphononongwa komngcipheko kubantu abaqhelekileyo (kubandakanywa nosulelo olungenazimpawu) nokuba nokwenzeka kosulelo;
  • Uvavanyo lokukwazi ukumelana nentsholongwane.

  • Ngaphambili:
  • Okulandelayo:

  • Ukubuza